124 related articles for article (PubMed ID: 38447293)
21. Attending the breast screening programme after breast cancer treatment: a population-based study.
de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
[TBL] [Abstract][Full Text] [Related]
22. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
[TBL] [Abstract][Full Text] [Related]
23. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
[TBL] [Abstract][Full Text] [Related]
25. Mammographic surveillance of asymptomatic breast cancer relatives in general practice: rate of re-attendance and GP- and patient-related barriers.
Duijm LE; Guit GL; Zaat JO
Fam Pract; 1997 Dec; 14(6):450-4. PubMed ID: 9476075
[TBL] [Abstract][Full Text] [Related]
26. Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening.
Duijm LE; Groenewoud JH; Jansen FH; Fracheboud J; van Beek M; de Koning HJ
Br J Cancer; 2004 Nov; 91(10):1795-9. PubMed ID: 15505630
[TBL] [Abstract][Full Text] [Related]
27. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
[TBL] [Abstract][Full Text] [Related]
28. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
29. Dutch digital breast cancer screening: implications for breast cancer care.
Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
[TBL] [Abstract][Full Text] [Related]
30. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
[TBL] [Abstract][Full Text] [Related]
31. Screening for breast cancer in Nijmegen. Report of 6 screening rounds, 1975-1986.
Peeters PH; Verbeek AL; Hendriks JH; van Bon MJ
Int J Cancer; 1989 Feb; 43(2):226-30. PubMed ID: 2917799
[TBL] [Abstract][Full Text] [Related]
32. Factors Impacting False Positive Recall in Screening Mammography.
Honig EL; Mullen LA; Amir T; Alvin MD; Jones MK; Ambinder EB; Falomo ET; Harvey SC
Acad Radiol; 2019 Nov; 26(11):1505-1512. PubMed ID: 30772138
[TBL] [Abstract][Full Text] [Related]
33. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
[TBL] [Abstract][Full Text] [Related]
34. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
35. Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis.
Dabbous FM; Dolecek TA; Berbaum ML; Friedewald SM; Summerfelt WT; Hoskins K; Rauscher GH
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):397-403. PubMed ID: 28183826
[No Abstract] [Full Text] [Related]
36. Consequences of digital mammography in population-based breast cancer screening: initial changes and long-term impact on referral rates.
Bluekens AM; Karssemeijer N; Beijerinck D; Deurenberg JJ; van Engen RE; Broeders MJ; den Heeten GJ
Eur Radiol; 2010 Sep; 20(9):2067-73. PubMed ID: 20407901
[TBL] [Abstract][Full Text] [Related]
37. The effect of false positive breast screening examinations on subsequent attendance: retrospective cohort study.
Maxwell AJ; Beattie C; Lavelle J; Lyburn I; Sinnatamby R; Garnett S; Herbert A
J Med Screen; 2013 Jun; 20(2):91-8. PubMed ID: 24009091
[TBL] [Abstract][Full Text] [Related]
38. Radiologists' interpretive efficiency and variability in true- and false-positive detection when screen-reading with tomosynthesis (3D-mammography) relative to standard mammography in population screening.
Svahn TM; Macaskill P; Houssami N
Breast; 2015 Dec; 24(6):687-93. PubMed ID: 26433751
[TBL] [Abstract][Full Text] [Related]
39. Participation behaviour following a false positive test in the Copenhagen mammography screening programme.
Andersen SB; Vejborg I; von Euler-Chelpin M
Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321
[TBL] [Abstract][Full Text] [Related]
40. Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use.
Blanchard K; Colbert JA; Kopans DB; Moore R; Halpern EF; Hughes KS; Smith BL; Tanabe KK; Michaelson JS
Radiology; 2006 Aug; 240(2):335-42. PubMed ID: 16864665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
